How effective is Baricitinib in treating COVID-19?

Baricitinib (Baricitinib) is a Janus kinase inhibitor originally used to treat rheumatoid arthritis. In recent years, baricitinib has also been used to treat patients with new coronavirus pneumonia (COVID-19), and some studies have evaluated its efficacy. Here’s what’s currently known about baricitinib’s efficacy in treating COVID-19:

1.Used in combination with other drugs: Baricitinib is often used in combination with other antiviral drugs (such as raninastat) to improve the therapeutic effect.

2.Reduce inflammatory response:Severe cases of COVID-19 are often accompanied by an excessive immune response and inflammation, leading to lung damage and other complications. Baricitinib has anti-inflammatory effects and can reduce pulmonary inflammatory response by inhibiting inflammatory signaling pathways.

3.Shorter length of stay: Some studies have shown that baricitinib can significantly shorten the length of stay and reduce the need for ventilators in patients with severe COVID-19.

4.Improving clinical outcomes: Preliminary study results show that baricitinib may help reduce symptom severity and risk of disease progression in patients withCOVID-19.

While there are some preliminary findings suggesting baricitinib has some potential in the treatment ofCOVID-19, more clinical studies are needed to fully evaluate its efficacy and safety. It is important to note that baricitinib as a treatment for COVID-19 is not suitable for all patients and still needs to be used under the guidance of a physician.

Baricitinib has been launched in China and is included in medical insurance. Patients can purchase it domestically. Due to different medical insurance reimbursement policies in various places, the reimbursement ratio is also different. The price is about 1200~1600It’s about RMB 1,000. For specific prices, please consult your local pharmacy or medical insurance bureau. Baricitinib has both original and generic drugs abroad. The original drug is mainly Eli Lilly’s original drug, and its price is higher than in China. Generic drugs are mainly Bangladeshi generic drugs, and the price is around 450 yuan. The ingredients of original drugs and generic drugs are basically the same.